We study our method theoretically, evaluate finite sample properties in a simulation study and demonstrate its efficacy in an application to diagnosis of Alzheimer’s disease via ratios of amyloid-beta and total tau protein biomarkers. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.